ÂÜÀòÂÒÂ×

John Krayacich is Senior Vice President and Head of Global Business Development at LEO Pharma where he is responsible for in-licensing, out-licensing, divestments and Mergers and Acquisitions. Prior to LEO, John was Vice President, Strategic Planning and Business Development & Licensing at Novartis Pharmaceuticals Corporation.

Prior to that role, John spent over 25 years with large multinational healthcare companies including Pfizer and Warner-Lambert/Parke-Davis, where he held positions of increasing responsibility for global and in-country business development, strategic planning, project management, drug development, and sales / marketing. He also had responsibility in two separate President & CEO roles for early stage biotechnology development companies, Marinus Pharmaceuticals and Ambrose Pharmaceuticals, respectively.

John earned his Honors Bachelor of Science and Master of Science in Physiology as well as his Master’s in Business Administration from the Ivey Business School at The University of Western Ontario, Canada.

John is married with three grown children, enjoys spending time with his family, is an active squash player, and can also often be found golfing, biking or hiking in the mountains on the weekends.